Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1)
This trial will study the effectiveness of photodynamic therapy with aminolaevulinic acid for the treatment of patients with HPV+ low grade cervical intraepithelial neoplasia (LSIL;CIN1).
Cervical Intraepithelial Neoplasia|Low-Grade Squamous Intraepithelial Lesions|Papillomavirus Infections
DRUG: Aminolaevulinic acid|DRUG: Placebo
Response rate, Based on histology, cytology and HPV status. "Response" is defined as: 1) pathology and cytology were both normal; 2) pathology and/or cytology showed low grade and the baseline HPV infection was cleared., 3 months after treatments|Complete response rate, Based on histology, cytology and HPV status. "Complete response" is defined as normal pathology, normal cytology and negative HPV., 3 months after treatments|Clearance of high risk HPV, Proportion of patients with high risk HPV clearance, 3 months after treatments
This trial will study the effectiveness of photodynamic therapy with aminolaevulinic acid for the treatment of patients with HPV+ low grade cervical intraepithelial neoplasia (LSIL;CIN1).